Radiofrequency for Acne

N/A

Recruiting

Research Sponsored by Pollogen

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, and optional 9 months post last treatment visit.

Awards & highlights

No Placebo-Only Group

Summary

"This trial will test if fractional radiofrequency is safe and effective for treating moderate to severe acne vulgaris."

Who is the study for?

This trial is for 18-25 year-olds with moderate to severe facial acne, defined by specific criteria. Participants must be on tetracycline antibiotics and off other acne treatments for set periods before the study. They should have a balanced acne condition on both sides of their face and agree to birth control if applicable.

What is being tested?

The trial tests the safety and effectiveness of fractional radiofrequency (RF) using triLift/Legend Pro+ system in treating moderate to severe acne vulgaris compared to standard treatments.

What are the potential side effects?

Potential side effects may include temporary redness, swelling, or irritation at the treatment site due to RF energy exposure. These are common reactions following RF procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, and optional 9 months post last treatment visit.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, and optional 9 months post last treatment visit.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, and optional 9 months post last treatment visit. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Evaluate the Efficacy of Fractional RF for the Treatment of Moderate to Severe Acne Vulgaris

Secondary study objectives

Overall Improvement of Acne

Subjective Satisfaction with the Treatment Results

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

Open(self-controlled) split-face design study. Thirty participants will undergo the treatments on one side of the face (buccal area). Treatments will be randomized with combination antibiotic/ FRF therapy.

Do I qualify?Apply below to find out